Over the last 12 months, Septerna insiders reported no purchases and 10 sales totaling $1.7M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Long Daniel D.SVP, Drug Discovery · O | ▼ Sale | 3,334 | $34.47 | $115K | -3.3% | plan · 2 tranches |
| Jul 15, 2026 | Bhatt ElizabethPresident and COO · O | ▼ Sale | 4,000 | $33.99 | $136K | -2.2% | plan |
| Jul 1, 2026 | Long Daniel D.SVP, Drug Discovery · O | ▼ Sale | 3,333 | $34.36 | $115K | -3.3% | plan · 2 tranches |
| Jun 29, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 2,178 | $35.18 | $77K | -73.3% | plan |
| Jun 22, 2026 | Long Daniel D.SVP, Drug Discovery · O | ▼ Sale | 15,000 | $35.51 | $533K | -13.5% | plan · 2 tranches |
| Jun 12, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 6,250 | $35.08 | $219K | -88.7% | plan |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 2,889 | $29.66 | $86K | -78.5% | plan |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 1,346 | $28.79 | $39K | -26.8% | plan |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 1,700 | $27.78 | $47K | -25.3% | plan |
| May 26, 2026 | Shaikhly SamiraChief People Officer · O | ▼ Sale | 11,798 | $30.06 | $355K | -93.7% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SEPN feed.